Crude drug composition for preventing or treating respiratory diseases

A technology for respiratory diseases and compositions, applied in [0002] the field of the present invention, can solve problems such as untreatable and limited

Active Publication Date: 2020-10-30
HELIXMITH CO LTD
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, this conventional therapeutic agent for respiratory diseases is limited to the treatment of chronic obstructive pulmonary disease (COPD) in infants or children with allergic asthma and smokers
Moreover, most of the above-mentioned therapeutic agents are only used to relieve symptoms, and have limi

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Crude drug composition for preventing or treating respiratory diseases
  • Crude drug composition for preventing or treating respiratory diseases
  • Crude drug composition for preventing or treating respiratory diseases

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0090] Throughout this specification, unless otherwise mentioned, "%" used to express the concentration of a specific substance is solid / solid (weight / weight)%, solid / liquid (weight / volume)% and Liquid / liquid is (vol / vol) %.

preparation example 1

[0092] Preparation Example 1: Preparation of 4 kinds of compound crude drug extracts (mixed extracts)

[0093] The washed and dried mustard seeds, sand ginseng, honeysuckle and perilla seeds were used in the experiment. After mixing the crude drugs of the above-mentioned mustard seed, sand ginseng, honeysuckle, and perilla seed in a weight ratio of 1:1:1:1 to make the total weight 60 g, add 10 times 25% (v / v) ethanol aqueous solution to Stir well for 72 hours at room temperature and extract. The extract was filtered, concentrated under reduced pressure at a temperature of 50 to 65° C., and then freeze-dried to obtain a complex crude drug extract (mixed extract) in a powder state. The yield is 12-13%.

preparation example 2

[0094] Preparation Example 2: Preparation of 3 kinds of compound crude drug extracts (mixed extracts)

[0095] Washed and dried mustard seeds, sand ginseng and honeysuckle were used in the experiment. After mixing the crude drugs of mustard seed, sand ginseng, and honeysuckle in a weight ratio of 1:1:1 to make the total weight 60 g, add 10 times the 25% (v / v) ethanol aqueous solution to make it well under normal temperature conditions. Stir for 72 hours and extract. The extract was filtered, concentrated under reduced pressure at a temperature of 50 to 65° C., and then freeze-dried to obtain a complex crude drug extract (mixed extract) in a powder state. The yield is about 12-14%.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention relates to a pharmaceutical composition for preventing or treating respiratory diseases and a food composition for preventing or relieving respiratory diseases comprising as an active ingredient two or more mixed extracts selected from the group consisting of a Brassicae Semen extract, an Adenophorae Radix extract, a Lonicerae Folium extract and a Perillae Semen extract. A composition comprising mixed extracts of Brassicae Semen, Adenophorae Radix, Lonicerae Folium and Perillae Semen of the present invention has an advantage of preventing respiratory diseases and relieving the symptoms of respiratory diseases, restores damages in the lung tissue, inhibits aging action and inflammation induced by inflammation-inducing substances such as fine dust, and has an excellentantioxidant effect. More particularly, the composition of the present invention increases the expression of a telomerase which extends the length of a telomere, and thus is expected to fundamentally treat degenerative respiratory diseases induced by fine dust unlike existing symptom alleviating agents.

Description

technical field [0001] This application claims Korean Patent Application No. 10-2018-0031151 filed on March 16, 2018, Korean Patent Application No. 10-2018-0150900 filed on November 29, 2018 , the priority of Korean Patent Application No. 10-2019-0028959 filed on March 13, 2019, the entire contents of which are incorporated herein by reference. [0002] The present invention relates to a herbal medicine composition for preventing or treating respiratory diseases, specifically, a herbal composition comprising a compound selected from mustard (Brassicae Semen) extract, Adenophorae Radix (Adenophorae Radix) extract, honeysuckle (Lonicerae Folium) extract and perilla seed. A composition for preventing, treating, and improving respiratory diseases of a group consisting of two or more mixed extracts of (Perillae Semen) extracts. Background technique [0003] Respiratory diseases are diseases related to the lungs and respiratory tract, mainly caused by inhalation of harmful partic...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/31A61P11/06A61K36/344A61K36/355A61K36/535A23L33/105A61P11/00A61P11/04
CPCA23L33/105A61K36/31A61K36/344A61K36/355A61K36/535A61P11/00A61P11/04A61P11/06A61P11/16A61K9/0053A61K9/0095A61K2236/331A61K2236/333A61K2300/00A23V2002/00A23V2200/314A61K36/342A61K36/35A61K36/53
Inventor 孙美苑裴敏贞李元宇李头奭
Owner HELIXMITH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap